Episode 5: KdT Ventures' Founder and Managing Partner Cain McClary

episode

BioVenture VoiCes with Chris Garabedian not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Soufflage at the Staatstheater, by Jim Culleton 4 min · 20 Sep 2026 · Sunday Miscellany

NPR News: 09-20-2026 7AM EDT 5 min · 20 Sep 2026 · NPR News Now

7AM ET 09/20/2026 Newscast 3 min · 20 Sep 2026 · Fox News Hourly Update

Autumn and Harvest, by Grace Wells 4 min · 20 Sep 2026 · Sunday Miscellany

We Close in October, by Georg Grote 6 min · 20 Sep 2026 · Sunday Miscellany

District Club: Congress Breaks, Trump Contemplates Iran and Kamala Hits the Trail 46 min · 20 Sep 2026 · Morning Wire

Report any issue

Source

Recorded04 Nov 2024

Publisheranchor.fm ↗

Handlerec:1031934

Show notes

He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related